Status:

COMPLETED

HR021618 in Moderate to Severe Pain After Abdominal Surgery

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Conditions:

Pain After Abdominal Surgery

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

Brief Summary

The study is being conducted to evaluate the efficacy and safety of HR021618 in the treatment of moderate to severe pain after abdominal surgery.

Eligibility Criteria

Inclusion

  • Able and willing to provide a written informed consent
  • Subjects requiring elective general anesthesia abdominal surgery
  • Male or female
  • Meet BMI standard
  • Conform to the ASA Physical Status Classification

Exclusion

  • Subjects with a history of abdominal surgery
  • Subjects had hemorrhagic disorders
  • Subjects had cardiac, serious hepatic or renal, cardiovascular or cerebrovascular, metabolic, psychiatric disorders, chronic pain, or malignant tumors
  • Subjects with poor blood pressure control after medication
  • Abnormal QTc
  • Abnormal random blood glucose
  • Abnormal values in the laboratory
  • Allergic to meloxicam or any excipient of HR021618, aspirin, other non-steroidal anti-inflammatory drugs (NSAIDs) or to any peri- or postoperative medications used in this study
  • Use other drugs that affect the analgesic effect before randomization, and the time from the last use to randomization is shorter than 5 half-lives
  • Pregnant or nursing women
  • No birth control during the specified period of time
  • Participated in clinical trials of other drugs (received experimental drugs)
  • The inestigators determined that other conditions were inappropriate for participation in this clinical trial

Key Trial Info

Start Date :

April 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 15 2021

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT04811053

Start Date

April 12 2021

End Date

July 15 2021

Last Update

May 15 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

West China Hospital, Sichuan University

Chengdu, Sichuan, China, 610041